Corticosteroid Injection Versus Nerve Block
Recruiting · NCT06735027 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Minnesota
View the official record on ClinicalTrials.gov →Interventions studied
intraarticular corticosteroid injection (IACI)suprascapular nerve block (SSNB)
What this trial is about
The purpose of this study is to evaluate conservative pain relief measures for patients suffering from glenohumeral arthritis or rotator cuff arthropathy. Conservative management of osteoarthritis is often first line treatment, and while a corticosteroid injection is frequently used, suprascapular nerve blocks have not often been described as an analgesic option in this population.
Who can take part
Age range
18 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- diagnosis of glenohumeral osteoarthritis, rheumatoid arthritis, or rotator cuff arthropathy who are being offered injection
Exclusion criteria
- uncontrolled diabetes (patients will be excluded if no HbA1c within a year or if it is 8 or greater"
- known allergy to steroid or anesthetic
- pregnant women
- prisoners
- patients with diminished capacity to consent to participation
- children under 18 years of age
- non-English speakers
Where it is running
1 location listed across 1 US state.
- University of Minnesota - Minneapolis, Minnesota, United States